REGISTERED NUMBER: 08340304 (England and Wales)

Report of the Directors and

Unaudited Financial Statements for the Year Ended 31 December 2024

for

London Medics Ltd

Page

Company Information

1

Report of the Directors

2

Balance Sheet

3

Notes to the Financial Statements

5

DIRECTORS:

Dr Sohail Rana

Mrs Saira Rana

REGISTERED OFFICE:

House No. 1

Moat Road

Salford

M6 6LR

REGISTERED NUMBER:

08340304 (England and Wales)

ACCOUNTANTS:

Argon & Krypton Consulting Ltd

(Chartered Certified Accountants & Tax Advisers)

Unit 6

Town Quay Wharf

Abbey Road

Barking

Essex

IG11 7BZ

The directors present their report with the financial statements of the company for the year ended 31 December 2024.

PRINCIPAL ACTIVITY

The principal activity of the company in the year under review was that of General Medical practice and Hospital Activities

DIRECTORS

The directors set out in the table below have held office during the whole of the period from 1 January 2024 to the date of this report.

The beneficial interests of the directors holding office at 31 December 2024 in the shares of the company, according to the register of directors' interests, were as follows:

31.12.24

1.1.24

Ordinary Shares shares of £1 each

Dr Sohail Rana

400

400

Mrs Saira Rana

600

600

These directors did not hold any non-beneficial interests in the shares of the company.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:

Dr Sohail Rana - Director

10 September 2025

FIXED ASSETS

Tangible assets

4

2,657

6,045

CURRENT ASSETS

Cash at bank

13,199

1,794

CREDITORS

Amounts falling due within one year

5

50,466

44,364

NET CURRENT LIABILITIES

(37,267

)

(42,570

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(34,610

)

(36,525

)

CREDITORS

Amounts falling due after more than one year

6

(19,781

)

(23,537

)

ACCRUALS AND DEFERRED INCOME

(30,366

)

(399

)

NET LIABILITIES

(84,757

)

(60,461

)

CAPITAL AND RESERVES

Called up share capital

7

1,000

1,000

Retained earnings

8

(85,757

)

(61,461

)

SHAREHOLDERS' FUNDS

(84,757

)

(60,461

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2025 and were signed on its behalf by:

Dr Sohail Rana - Director

1.	STATUTORY INFORMATION

London Medics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1 January 2024

and 31 December 2024

12,642

DEPRECIATION

At 1 January 2024

6,597

Charge for year

3,388

At 31 December 2024

9,985

NET BOOK VALUE

At 31 December 2024

2,657

At 31 December 2023

6,045

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Trade creditors

5,099

5,085

Corporation Tax Payable

30,870

26,233

PAYE

14,497

13,046

50,466

44,364

6.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.12.24

31.12.23

£

£

Bounce Back Loan

19,781

23,537

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.24

31.12.23

value:

£

£

1,000

Ordinary Shares

£1

1,000

1,000

The Total Share Capital is 1000 Ordinary Shares, and the Prescribe Right of Each Share are given below

Each Share is entitled to one Vote in any circumstances

Each share has equal rights to dividends

Each Share is entitled to participate in a distribution arising from a winding up of the company

8.

RESERVES

Retained

earnings

£

At 1 January 2024

(61,461

)

Profit for the year

16,381

Dividends

(40,677

)

At 31 December 2024

(85,757

)